ties; social life; energy life; pain; diet, eating and drinking habits; emotional life; sleep; fatigue/wakefulness; diarrhea/stomal output; skeletal/muscle symptoms; other symptoms/discomfort; all P < 0.05); for 3 items (physical health, mobility/self‐care, and GI symptoms) scores were improved but did not achieve significance vs placebo (Table 2 ).
← all excerpts
Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
1
—
—